The Study of Tranexamic Acid suppression fibrinolysis for Endoleak before Endovascular Repair for Aortic Aneurysm

The Study of Tranexamic Acid suppression fibrinolysis for Endoleak before Endovascular Repair for Aortic Aneurysm - The Study of Tranexamic Acid for Endoleak before Endovascular Repair for Aortic Aneurysm

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024202

Enrollment

150

Registered

2016-09-30

Start date

2017-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic aneurysma

Interventions

Patients are added the Tranexamic acid(1500mg/day) for 30days just before stentgraft treatment.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Aortic aneurysms patients with indication for stentgraft implantation

Exclusion criteria

Exclusion criteria: aneurysms patients without indication for stentgraft implantation

Design outcomes

Primary

Measure	Time frame
(enhanced) CT and US view, 1month, 3month, 6month, 1to5years after operation	—

Secondary

Measure	Time frame
labo data (especially D-dimer)	—

Countries

Japan

Contacts

Public ContactSusumu Oozawa

Okayama University Hospital Cardiovascular surgery

ohzawa-s@cc.okayama-u.ac.jp+81-86-235-7359

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026